INOVIO PHARMACEUTICALS, INC. Revenue, Net (Deprecated 2018-01-31)
INOVIO PHARMACEUTICALS, INC. (INO) reported Revenue, Net (Deprecated 2018-01-31) of $42.22 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-14.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-03-14
- INOVIO PHARMACEUTICALS, INC. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $42.22M, a 19.37% increase from fiscal 2016.
- INOVIO PHARMACEUTICALS, INC. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $35.37M, a 12.83% decline from fiscal 2015.
- INOVIO PHARMACEUTICALS, INC. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $40.57M, a 288.00% increase from fiscal 2014.
- INOVIO PHARMACEUTICALS, INC. revenue, net (deprecated 2018-01-31) for fiscal 2014 was $10.46M, a 22.35% decline from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|
| 2017-12-31 | $42.22M 10-K · filed 2018-03-14 |
| 2016-12-31 | $35.37M 10-K · filed 2018-03-14 |
| 2015-12-31 | $40.57M 10-K · filed 2018-03-14 |
| 2014-12-31 | $10.46M 10-K · filed 2017-03-15 |
| 2013-12-31 | $13.47M 10-K · filed 2016-03-14 |
| 2012-12-31 | $4.12M 10-K · filed 2015-03-16 |
| 2011-12-31 | $9.80M 10-K · filed 2014-03-17 |
| 2010-12-31 | $6.14M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |